Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lineage Commitment01:21

Lineage Commitment

3.0K
Commitment is the  process whereby stem cells:
3.0K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Combinatorial Gene Control02:33

Combinatorial Gene Control

8.3K
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
8.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Nicotinamide Salvage Pathway is a Metabolic Vulnerability of High-Risk MDS Stem Cells.

bioRxiv : the preprint server for biology·2026
Same author

A generalized strategy to kill leukemic cells by targeting the regulatory systems governing mitochondrial membrane potential.

Cell reports·2025
Same author

Activation of a nongenetic AHR-ELMSAN1 axis optimizes BET-targeting therapy and suppresses leukemia stem cells in preclinical models.

Science translational medicine·2025
Same author

The Soil Bacterial Community Structure in a <i>Lactarius hatsudake</i> Tanaka Plantation during Harvest.

Microorganisms·2024
Same author

A Lu<sub>3</sub>Sc<sub>2</sub>Ga<sub>3</sub>O<sub>12</sub>: Eu<sup>3+</sup> red-emitting phosphor with excellent optical properties and thermal stability was obtained by partially replacing Lu<sup>3+</sup> with Gd<sup>3+</sup> / Y<sup>3</sup>.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2024
Same author

Drug-Resistant Profiles and Genetic Diversity of <i>Mycobacterium</i> Tuberculosis Revealed by Whole-Genome Sequencing in Hinggan League of Inner Mongolia, China.

Infection and drug resistance·2024
Same journal

Should flow cytometry be required for CMML diagnosis? Position of the ELN iMDS Flow Working Group.

HemaSphere·2026
Same journal

Idecabtagene vicleucel and endogenous T-cell phenotypes linked to progression-free survival in relapsed multiple myeloma.

HemaSphere·2026
Same journal

Multiple myeloma: A tale of deregulated transcription factors.

HemaSphere·2026
Same journal

Transitioning CAR-T therapy for multiple myeloma to the outpatient setting: First clinical insights with cilta-cel in Germany.

HemaSphere·2026
Same journal

Genome-wide association study in 21,271 individuals identifies 9 novel loci associated with circulating CD34<sup>+</sup> hematopoietic stem and progenitor cell levels.

HemaSphere·2026
Same journal

Systemic barriers to recruitment of blood donors from African, Caribbean, and Black communities.

HemaSphere·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2025

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

9.9K

RNA binding protein-directed control of leukemic stem cell evolution and function.

Pratik Joshi1,2, Ava Keyvani Chahi2, Lina Liu2

  • 1Department of Medical Biophysics University of Toronto Toronto Canada.

Hemasphere
|August 23, 2024
PubMed
Summary
This summary is machine-generated.

RNA-binding proteins (RBPs) are crucial for healthy blood production. Their dysregulation in myeloid disorders and acute myeloid leukemia (AML) highlights RBPs as potential therapeutic targets.

More Related Videos

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation
11:40

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation

Published on: October 20, 2014

8.5K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.2K

Related Experiment Videos

Last Updated: Jun 15, 2025

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

9.9K
Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation
11:40

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation

Published on: October 20, 2014

8.5K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.2K

Area of Science:

  • Hematology
  • Molecular Biology
  • Cancer Research

Background:

  • Hematopoietic stem cell (HSC) regulation is vital for lifelong blood production and preventing hematopoietic diseases.
  • Acute myeloid leukemia (AML) originates from primitive cells acquiring genetic changes, leading to leukemic stem cells (LSCs).
  • Understanding LSC development is key for leukemia interception and targeted AML therapies.

Purpose of the Study:

  • To explore myeloid dysregulation at the post-transcriptional level, focusing on RNA-binding proteins (RBPs).
  • To investigate the role of RBPs and their networks in healthy hematopoiesis and AML pathogenesis.
  • To highlight RBPs as actionable targets for precision therapy in AML.

Main Methods:

  • Review of current literature on RBPs and post-transcriptional control in hematopoiesis and AML.
  • Emphasis on findings from human stem cells.
  • Analysis of RBP networks in myeloid disorders and AML.

Main Results:

  • RBPs are core effectors in post-transcriptional control, orchestrating RNA metabolism to regulate gene expression.
  • Dysregulation of RBPs and their networks is implicated in clonal myeloid disorders and AML pathogenesis.
  • Human stem cell studies provide critical insights into RBP function in these diseases.

Conclusions:

  • RBPs play a significant role in maintaining healthy hematopoiesis.
  • Altered RBP function contributes to the development of myeloid malignancies.
  • RBPs and post-transcriptional control represent promising targets for precision AML therapy.